Ninewells Hospital and Medical School, Dundee, Scotland DD1 9SY, UKE-mail: g.a.mcleod@dundee.ac.uk
Declaration of interest. The author has, in the past, received financial help from Chiroscience, Cambridge, UK and Abbott Laboratories, Chicago, Illinois for employment of research personnel and he has received honoraria for presentations at medical meetings. The author has also designed and analysed studies in obstetric anaesthesia for Astra Zeneca research fellows.
Accepted for publication: November 5, 2003
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Methods. Density (mg ml1) was measured using the method of mechanical oscillation resonance, accurate to five decimal places on 1250 samples. 500 density measurements were performed in a randomized, blind fashion at 23 and 37°C on 10 plain solutions of bupivacaine (2.5, 5, and 7.5 mg ml1) levobupivacaine (2.5, 5, and 7.5 mg ml1) and ropivacaine (2, 5, 7.5, and 10 mg ml1). Following this, 750 density measurements were taken at 23 and 37°C on the 5 mg ml1 solutions of bupivacaine, levobupivacaine, and ropivacaine with added dextrose (10, 20, 30, 50, and 80 mg ml1).
Results. There was a linear relationship between density and dextrose concentration for all three local anaesthetics (R2=0.99) at 23 and 37°C. The mean density of levobupivacaine 5 mg ml1 was significantly greater than the densities of bupivacaine 5 mg ml1 and ropivacaine 5 mg ml1 after adjusting for dextrose concentration using analysis of covariance. This difference existed both at 23 and 37°C. The mean (SD) density of levobupivacaine 7.5 mg ml1 was 1.00056 (0.00003) mg ml1, the lower 0.5% percentile (1.00047 mg ml1) lying above the upper limit of hypobaricity for all patient groups.
Conclusions. The density of local anaesthetics decreases with increasing temperature and increases in a linear fashion with the addition of dextrose. Levobupivacaine 5 mg ml1 has a significantly higher density compared with bupivacaine 5 mg ml1 and ropivacaine 5 mg ml1 at 23 and 37°C both with and without dextrose. Levobupivacaine 7.5 mg ml1 is an isobaric solution within all patient groups at 37°C.
Br J Anaesth 2004; 92: 54751
Keywords: anaesthetic solutions, density; anaesthetic techniques, intrathecal; anaesthetics local, bupivacaine; anaesthetics local, levobupivacaine; anaesthetics local, ropivacaine; physics, baricity
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Plain solutions of bupivacaine with a density of 0.9993 g ml1 at 37°C are hypobaric in all patients. Clinically, this manifests as an unpredictable median sensory block height with a large inter-individual spread6 and is occasionally associated with block failure when the spinal block has not spread high enough for surgery.
Addition of dextrose to local anaesthetics increases the density of injectate and provides a predictable and consistently high sensory block.7 Unfortunately, two problems arise with high spinal blocks. First, profound sympathetic block as a result of extensive spinal block may enhance vagal tone, precipitate cardiac ischaemia, and possible cardiac arrest,8 and secondly, the duration of sensory block is significantly shortened.9
Several studies of spinal anaesthesia for lower limb, urological surgery, and Caesarian section with bupivacaine (8 mg ml1 dextrose)10 and ropivacaine (10 mg ml1 dextrose)11 12 have demonstrated that addition of a small amount of dextrose to local anaesthetics provides a reliable and sufficient sensory block within a small range of median maximal block height. The availability of new local anaesthetics such as levobupivacaine and ropivacaine and their increased use in practice as intrathecal agents, affords the opportunity of assessing the density and composition of new solutions with and without dextrose before embarking on clinical studies.
![]() |
Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Calibration of the glass tube, otherwise known as factor (F) determination, was determined from the oscillation periods of desiccated air (A=0.99114 g ml1) and distilled deionized water (
W=0.99333 g ml1) at 37°C according to the formula F=(
A
W)/(TA2 TW2) where TA is the period of oscillation of air and TW is the period of oscillation of water. Calculation of density (
S) uses the formula
S=
A F(TA2 TS2) where TS is the period of oscillation of the test solution.
Density measurements and calibration of the densitometer were performed by the University Department of Anaesthesia Research Nurse who established, before the study, a standardized technique. Local anaesthetic solutions with the same batch number were prepared by the author and the Research Nurse remained blind to the contents. Sixty millilitres of solutions were mixed (Table 1) within a sterile glass container with a tight fitting screw top, which was placed horizontally on to rollers within an electronic temperature controlled water bath set at either 23 or 37°C. These temperatures were chosen first to show the difference in density of local anaesthetics at room and body temperature and secondly to validate the methodology when measuring density at 37°C. The methodology involved automatically oscillating the solution within the water bath for 1 h in order to minimize microbubble formation. Microbubbles, invisible to the naked eye, are responsible for quite erroneous measurements of density. Following oscillation and de-gassing, five, 10 ml syringes were prepared by the author. Ten millilitre syringes allowed ease of injection of 2 ml samples into the port of the densitometer. Thus, 25 density measurements of each prepared solution were recorded to five decimal places by the research nurse.
|
In the first part of the study, nine concentrations of commercially available plain local anaesthetics were measured at 23 and 37°C; 2.5, 5, and 7.5 mg ml1 preparations of bupivacaine and levobupivacaine and 2, 7.5, and 10 mg ml1 solutions of ropivacaine. As clinical intrathecal studies have been performed with dextrose containing solutions of 5 mg ml1 ropivacaine12 a preparation was made by a 50:50 dilution of 1 mg ml1 ropivacaine with sterile saline. Thus, at each temperature, 250 measurements of density were made from 10 different plain local anaesthetics.
For the second part of the study, dextrose was added in concentrations of 10, 20, 30, 50, and 80 mg ml1 using the above standardized technique (Table 1) in such a way that the concentration of local anaesthetic was 5 mg ml1. At each temperature, a total of 375 density measurements were made from 15 solutions of three local anaesthetics at five different concentrations of dextrose.
Statistical analysis
Repeated measures analysis of variance was initially used to compare the variability of measurement within each syringe to the variability between syringes. Changes in density as a result of increased concentration of plain local anaesthetic were compared using one way analysis of variance and the post-hoc TukeyKramer Multiple-Comparison Test. With regard to 5 mg ml1 preparations of each local anaesthetic with and without added dextrose, linear regression analysis first determined the best approximation of a straight-line relationship between density and dextrose concentration, then an F ratio was calculated to determine if these slopes were equal. Subsequently, analysis of covariance (ANCOVA) was applied to the data to determine any differences in density between local anaesthetics while controlling for dextrose concentration. Similiarly, ANCOVA was used to measure difference in density between plain solutions while controlling for temperature. All recordings are presented as mean and 3 SD. Each commercial solution was also analysed in Ninewells Hospital Biochemistry Department for sodium, potassium ions, osmolality, and pH. Statistical analysis was performed using Number Cruncher Statistical Systems (NCSS), Hayes, Utah.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Plain solutions
Increasing the concentration of bupivacaine and levobupivacaine from 2.5 to 5 mg ml1 and 7.5 mg ml1 significantly increased the density of the latter solutions using one way analysis of variance F-ratio 191.4, P<0.01 for bupivacaine and F-ratio 4329.9, P<0.01 for levobupivacaine P<0.01. Increasing the concentration of ropivacaine up to 10 mg ml1 also significantly increased density, F-ratio 34.8, P,0.01. The exception was between 5 and 7.5 mg ml1 ropivacaine for which no difference in density was observed.
Effect of temperature
Mean (SD) density of each local anaesthetic solution was significantly different; higher at 23 compared with 37°C (Table 2). The slope of the reduction in density with increasing temperature was equivalent for all plain local anaesthetics, F-ratio for equality of slope=62.9, P<0.01. For every increase in temperature by 1°C between 23 and 37°C the density of all plain solutions fell by 0.0003 mg ml1. ANCOVA using density as the independent variable and temperature as the covariate, showed that the adjusted means (for temperature) of local anaesthetics to be significantly different F-ratio=63.1, P<0.01.
|
|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The rank order of density of bupivacaine, levobupivacaine, or ropivacaine is the same at temperatures of 23 and 37°C and is consistent over the range of dextrose concentrations used in clinical practice. Analysis was performed at 23 and 37°C to illustrate the relationship between densities of local anaesthetic formulations before and after clinical intrathecal injection. As thermal equilibrium occurs quickly within CSF, it is highly unlikely that density at 23°C has any relevance to spread. However, the consistency of measurement of adjusted means and slope over a range of dextrose concentrations at 37°C was similar to measurement at 23°C and justifies our rigorous methodology for de-gassing of solutions by oscillation in a water bath heated to 37°C for 1 h. Initial pre-study measurements of density were highly variable and sometimes unrecordable at 37°C as microbubbles are responsible for erroneous measurements of density. This is the first study to describe this phenomenon with regard to measurement of local anaesthetic density.
A linear relationship existed between the density of bupivacaine, levobupivacaine, or ropivacaine and increasing dextrose concentration at 23 and 37°C. The F ratio for equality of slopes was 20.7, P<0.01 at 23°C and 3.7, P=0.02 at 37°C. The derived slope (3.1x104 to 3.3x104) is in agreement with a study by Hare and colleagues13 in which density was measured using multiple dilutions but is higher than that calculated by Hallworth and colleagues14 albeit using solutions up to 10 mg ml1 dextrose. With incremental addition of dextrose to 5 mg ml1 bupivacaine, levobupivacaine, and ropivacaine, consistent and significant differences existed between local anaesthetics at 23°C, F ratio 99.0, P<0.01 and 37°C, F ratio 12.8, P<0.01.
All concentrations of bupivacaine and ropivacaine were hypobaric when measured at 37°C. These results compare favourably with laboratory studies performed with bupivacaine and ropivacaine using the same oscillometric technology accurate to five decimal places.4 5 14 In contrast, the mean (SD) density of levobupivacaine 7.5 mg ml1 was 1.00056 (0.00003) mg ml1, the lower 0.5% percentile (1.00047 mg ml1) lying above the upper limit of hypobaricity for all patient groups and thus can be regarded as an isobaric solution. Levobupivacaine 5 mg ml1 (1.00024 (0.00003) mg ml1) is slightly hypobaric according to the definition of Richardson and Wissler4 but may be regarded as isobaric within males and postmenopausal women according to the results of Lui and colleagues.5
The increased density of levobupivacaine may be attributable to its higher sodium ion content and higher osmolality compared with bupivacaine and ropivacaine. As the concentration of levobupivacaine is increased, sodium concentration is held constant, whereas as the concentration of bupivacaine and ropivacaine is increased, sodium concentration is reduced. In addition, there is a 13% additional contribution to osmolality by levobupivacaine compared with bupivacaine. Ampoules of levobupivacaine contain 7.5 mg ml1 free base (26.0 mmol litre1) whereas corresponding ampoules of bupivacaine contain 6.66 mg ml1 free base (23.1 mmol litre1) and ampoules of ropivacaine 6.63 mg ml1 (24.1 mmol litre1).
Although mathematically the lower limit of hyperbaricity may be defined as 3 SD above the mean, the actual density at which local anaesthetics behave consistently as a hyperbaric solution is not known. Other determinants of spread include patient posture, composition of solution, type of needle, level and speed of injection, volume,15 viscosity, and protein content of CSF,5 and in pregancy, inferior vena cava obstruction.11
Furthermore, opioids are often added to spinal preparations of local anaesthetics to improve anaesthesia and prolong post-operative analgesia. Opioids such as fentanyl are hypobaric (0.9933 mg ml1) and when added to a local anaesthetic will render the subsequent mixture even more hypobaric. The degree to which this occurs is proportional to the respective densities and volumes of individual drugs.13 Although changes in density may seem minimal and clinically unnnecessary, a change in density as low as 0.0006 mg ml1 may influence spread of local anaesthetic.2
In conclusion, this study has shown that the density of bupivacaine, levobupivacaine, and ropivacaine fell with increasing temperature and increased with added dextrose in a predictable, linear fashion. Significant differences existed between all three local anaesthetics when added to dextrose at both 23 and 37°C. Levobupivacaine 7.5 mg ml1 is isobaric in all patient groups.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
2 Stienstra R, Gielen M, Kroon JW, Van Poorten F. The influence of temperature and speed of injection on the distribution of a solution containing bupivacaine and methylene blue in a spinal canal model. Reg Anesth 1990; 15: 611[ISI][Medline]
3 Connolly C, Wildsmith JA. Intrathecal drug spread. Can J Anaesth 1998; 45: 28992[ISI][Medline]
4 Richardson MG, Wissler RN. Density of lumbar cerebrospinal fluid in pregnant and nonpregnant humans. Anesthesiology 1996; 85: 32630[CrossRef][ISI][Medline]
5 Lui AC, Polis TZ, Cicutti NJ. Densities of cerebrospinal fluid and spinal anaesthetic solutions in surgical patients at body temperature. Can J Anaesth 1998; 45: 297303[Abstract]
6 Logan MR, McClure JH, Wildsmith JA. Plain bupivacaine: an unpredictable spinal anaesthetic agent. Br J Anaesth 1986; 58: 2926[Abstract]
7 Sanderson P, Read J, Littlewood DG, McKeown D, Wildsmith JA. Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread. Br J Anaesth 1994; 73: 7446[Abstract]
8 Wahl A, Eberli FR, Thomson DA, Luginbuhl M. Coronary artery spasm and non-Q-wave myocardial infarction following intravenous ephedrine in two healthy women under spinal anaesthesia. Br J Anaesth 2002; 89: 51923
9 Kooger Infante NE, Van Gessel E, Forster A, Gamulin Z. Extent of hyperbaric spinal anesthesia influences the duration of spinal block. Anesthesiology 2000; 92: 131923[ISI][Medline]
10 Lee A, Ray D, Littlewood DG, Wildsmith JA. Effect of dextrose concentration on the intrathecal spread of amethocaine. Br J Anaesth 1988; 61: 1358[Abstract]
11 Connolly C, McLeod GA, Wildsmith JA. Spinal anaesthesia for Caesarean section with bupivacaine 5 mg ml1 in glucose 8 or 80 mg ml1. Br J Anaesth 2001; 86: 8057
12 Whiteside JB, Burke D, Wildsmith JA. Spinal anaesthesia with ropivacaine 5 mg ml1 in glucose 10 mg ml1 or 50 mg ml1. Br J Anaesth 2001; 86: 2414
13 Hare GM, Ngan JC. Density determination of local anaesthetic opioid mixtures for spinal anaesthesia. Can J Anaesth 1998; 45: 3416[Abstract]
14 Hallworth SP, Fernando R, Stocks GM. Predicting the density of bupivacaine and bupivacaine-opioid combinations. Anesth Analg 2002; 94: 16214
15 Carpenter RL, Hogan QH, Liu SS, Crane B, Moore J. Lumbosacral cerebrospinal fluid volume is the primary determinant of sensory block extent and duration during spinal anesthesia. Anesthesiology 1998; 89: 249[ISI][Medline]